Literature DB >> 17998698

Intensity modulated radiotherapy in abdominal malignancies: our experience in reducing the dose to normal structures as compared to the gross tumor.

Tejinder Kataria1, Sheh Rawat, S N Sinha, P S Negi, Charu Garg, N K Bhalla, R K Munjal.   

Abstract

BACKGROUND AND
PURPOSE: A better understanding of appropriate sequencing and use of multimodality approach in the management and subsequent improvement in overall survival mandates a vigil on quality of life issues. Intensity modulated radiotherapy (IMRT) is a powerful tool, which might go a long way in reducing radiation doses to critical structures and thereby reduce long term morbidities. The purpose of this paper is to evaluate the impact of IMRT in reducing the dose to the critical normal tissues while maintaining the desired dose to the volume of interest for abdominal malignancies.
MATERIALS AND METHODS: During the period January 2002 to March 2004, 11 patients of various sites of malignancies in the abdominal region were treated using physical intensity modulator based IMRT. Plans of these patients treated with IMRT were analyzed using dose volume histograms.
RESULTS: An average dose reduction of the mean values by 50% to the liver, 57% to the right kidney, 56% to the left kidney, 66% to the cord and 27% to the bowel, with respect to the GTV could be achieved with IMRT. The two-year disease free survival was 79% and two-year overall survival was 88%. The average number of IMRT fields used was six.
CONCLUSION: IMRT with inverse planning enabled us to achieve desired dose distribution, due to its ability to provide sharp dose gradients at the junction of tumor and the adjacent critical organs.

Entities:  

Mesh:

Year:  2006        PMID: 17998698     DOI: 10.4103/0973-1482.29825

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  3 in total

1.  Evaluation of dose coverage to target volume and normal tissue sparing in the adjuvant radiotherapy of gastric cancers: 3D-CRT compared with dynamic IMRT.

Authors:  Kk Murthy; Ka Shukeili; Ss Kumar; Ca Davis; Rr Chandran; S Namrata
Journal:  Biomed Imaging Interv J       Date:  2010-07-01

Review 2.  Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?

Authors:  Michael D Chuong; Drexell H Boggs; Kruti N Patel; William F Regine
Journal:  J Gastrointest Oncol       Date:  2014-06

3.  A Comparison of Gastrointestinal Toxicities between Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy for Pancreatic Cancer.

Authors:  Kyong Joo Lee; Hong In Yoon; Moon Jae Chung; Jeong Youp Park; Seungmin Bang; Seung-Woo Park; Jin Sil Seong; Si Young Song
Journal:  Gut Liver       Date:  2016-03       Impact factor: 4.519

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.